LONG BEACH, Calif.--(BUSINESS WIRE)--Jan. 18, 2012--
HCP (NYSE:HCP) priced an offering of $450 million of 3.75% senior
unsecured notes due 2019. The offering size was increased in response to
investor demand. The price to the investors was 99.523% of the principal
amount of the notes for an effective yield of 3.83%. The net proceeds of
the offering will be approximately $443.7 million, which will be used to
repay borrowings under HCP's revolving credit facility and for general
The offering is expected to close on January 23, 2012, subject to
customary closing conditions.
Citigroup, RBS and UBS Investment Bank acted as joint book-running
managers for the offering.
This offering of notes may be made only by means of a prospectus
supplement and a prospectus. A copy of the prospectus supplement and the
prospectus relating to the offering will be filed with the Securities
and Exchange Commission and, when available, can be obtained from:
(i) Citigroup, Brooklyn Army Terminal, 140 58th Street, 8th Floor,
Brooklyn, NY 11220, toll free at (800) 831-9146 or at firstname.lastname@example.org;
(ii) RBS Securities Inc., 600 Washington Boulevard, Stamford, CT 06901,
Toll free 1-866-884-2071; or (iii) UBS Securities LLC, 299 Park Avenue,
New York, New York 10171, Attention: Prospectus Specialist; or toll-free
at 877-827-6444, ext. 561 3884.
This communication shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
HCP, Inc., an S&P 500 company, is a real estate investment trust (REIT)
that invests primarily in real estate serving the healthcare industry in
the United States. HCP has been a publicly traded NYSE listed company
since 1985. HCP’s portfolio of properties is distributed among distinct
sectors of the healthcare industry, including senior housing,
post-acute/skilled nursing, life science, medical office and hospital.
The statements contained in this release which are not historical facts
are forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. These statements are subject to risks and uncertainties that could
cause actual results to differ materially from those set forth in or
implied by forward-looking statements. These risks and uncertainties
include general economic conditions and the ability of HCP to complete
the offering and receive the resulting proceeds. Some of these risks,
and other risks, are described from time to time in HCP's Securities and
Exchange Commission filings.
Source: HCP, Inc.
Timothy M. Schoen
Executive Vice President and Chief